New stent aims to keep leg arteries open longer

NCT ID NCT06410313

Recruiting now Disease control Sponsor: Medinol Ltd. Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 26, 2026 · Updated 1 time

Summary

This early study tests a new stent coated with a drug called ridaforolimus in 30 people with blocked arteries in the thigh or knee area. The stent is designed to prop the artery open and slowly release medication to prevent it from narrowing again. Participants will be followed for three years to see if the artery stays open and if the treatment is safe.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: ridaforolimus (drug-coated stent)
What this could lead to: If successful, this stent could offer a new option to keep leg arteries open longer, reducing the need for repeat procedures.
What could go wrong: This is a very early, small study (30 people) with no comparison group. The stent may not work as hoped, and risks include reblockage or complications from the procedure.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for POPLITEAL ARTERY STENOSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

POPLITEAL ARTERY STENOSIS SUPERFICIAL FEMORAL ARTERY STENOSIS

Contacts and locations

Locations

Columbia University Medical Center/ NewYork Presbyterian Hospital or CUMC/NYPH
NOT_YET_RECRUITING

New York, New York, 10032, United States
Piedmont Healthcare, Inc.
NOT_YET_RECRUITING

Atlanta, Georgia, 30318, United States
Royal North Shore Hospital
RECRUITING

Sydney, Australia
Royal Perth Hospital
NOT_YET_RECRUITING

Perth, Australia
Royal Prince Alfred Hospital
RECRUITING

Sydney, Australia
St Francis Hospital Heart Center
NOT_YET_RECRUITING

Roslyn, New York, 11576, United States
The Alfred Hospital
RECRUITING

Melbourne, Australia

More trials for these conditions

Other studies related to the condition(s) this trial covers.